Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 May 2023 | Story Samkelo Fetile | Photo iFlair Photography
Modular Lecture Building
The Modular Lecture Building on the UFS’s Bloemfontein Campus.

The University of the Free State’s (UFS) Modular Lecture Building on its Bloemfontein Campus recently received a National Merit Award from the South African Institute of Architects (SAIA). The awards were announced at the 2021/2022 Corobrik SAIA Awards of Merit and Awards for Excellence ceremony in Johannesburg.

The multi-functional Modular Lecture Building, considered a hub for innovative learning, was designed by Roodt Architects in partnership with GXY Architects.

The adjudication panel received a total of 42 architectural projects from around the country, including infrastructure developments in the public and private sector. The SAIA Awards programme is structured over a two-year period and is conducted in two stages. In stage one regional awards for architecture are presented by the nine regional institutes affiliated to SAIA. In stage two the winning regional projects that are consequently entered into the national awards receive either a Commendation, an Award of Merit, and/or an Award for Excellence, which recognises exceptional achievement in the field of architecture.

In their citation the adjudicators noted that the Modular Lecture Building sets a benchmark for rational planning and technical efficiency and helps complete the campus urban framework through its placing and material choices.

Multi-functional spaces for students

Nico Janse van Rensburg, Senior Director at UFS University Estates, said the recognition is a testament to the UFS’s aspirations to renew, rejuvenate, regenerate, and revisit facilities and infrastructure.

“This award proves that excellence can be achieved with a reasonable set budget,” Janse van Rensburg said. “Energy efficiency and green building principles can be achieved by careful planning and teamwork.”

The Modular Lecture Building offers a variety of much-needed flexible teaching and learning spaces. “I have been using the facilities in this building for two years now, and I can say the building is much more spacious and conducive to studying,” said Hymne Spies, a third-year BSc student majoring in biochemistry and genetics. “The many plugs make it more efficient for studying, as one can plug in his or her laptop. There is also a nice computer lab for us to make use of.”

The UFS is proud that the construction of this facility forms part of a bigger endeavour – to create a cohesive campus identity that improves core business and to further extend its innovation and excellence as per its Vision 130.

Take a tour of the new Modular Lecturing Space and Assessment Centre Building:

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept